Company intelligence / Profile preview

TWIICE

Lausanne, Vaud, Switzerlandtwiice.co.nz ↗

Ownership: Private
Development stage: Commercial

Overview

TWIICE has developed "TWIICE One," an advanced powered exoskeleton designed to enable individuals with spinal cord injuries or stroke-induced mobility impairments to stand and walk again. The device has undergone four generations of development and is currently being tested in a pivotal clinical trial at a leading European center. The product has won the Global Innovation Challenge and is preparing for market entry in the US and Germany, where reimbursement pathways are already established.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Partnerships

Collaboration with Europe's leading clinical center for pivotal trials

Beyond the preview

Go deeper on TWIICE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TWIICE.

Explore the full profile